Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 11546
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49867
Compare the "tingling" side effect of Brilacidin
(4)
Drano
10/12/2018 2:08:26 PM
49866
I absolutely agree with you. I just wanted to
(2)
RusticBum
10/12/2018 2:05:33 PM
49865
Could be...Leo could hand out $100 bills and
Commando911
10/12/2018 2:01:04 PM
49864
See 11 buys at .20 off the time and sales
(1)
NotRichYet2
10/12/2018 2:00:37 PM
49863
Ask is back at .20. They are probably trying to
(2)
Drano
10/12/2018 1:58:52 PM
49862
Maybe. Guessing they just couldn't find a 0.20
(2)
Squar
10/12/2018 1:35:53 PM
49861
yep and after hitting *high* of the day (HOD) ..
(3)
4kids
10/12/2018 1:34:32 PM
49860
Bid/ask was .18/.20 but that looked too positive
Drano
10/12/2018 1:30:34 PM
49859
yep PR email time stamp shows 1:17PM .. i have
(1)
4kids
10/12/2018 1:30:02 PM
49858
Oops, Im slow to trigger
Commando911
10/12/2018 1:24:01 PM
49857
Innovation Pharmaceuticals Brilacidin as a Novel
Commando911
10/12/2018 1:23:10 PM
49856
News just arrived via email. I agree nicely
AlanC
10/12/2018 1:22:28 PM
49855
Had a partial order fill just prior to the PR
(2)
4kids
10/12/2018 1:20:57 PM
49854
That isn't quite correct. PolyMedix had limited
(1)
Drano
10/12/2018 1:17:34 PM
49853
what i really like about today's update was its
(1)
4kids
10/12/2018 1:14:26 PM
49852
It's actually worse with Poly. They did lab tests
RusticBum
10/12/2018 1:13:58 PM
49851
Nice update! Keep working the plan Leo! Go
(2)
AlanC
10/12/2018 1:03:55 PM
49850
Yes, I was thinking about that also. There is
(1)
Jimmyboy
10/12/2018 12:49:52 PM
49849
You can tell that Leo DID NOT write that one --
(1)
Drano
10/12/2018 12:45:28 PM
49848
I'm convinced we are going to see some MAJOR
(1)
smokenhot
10/12/2018 12:28:16 PM
49847
Makes one wonder if it is the BP that is holding
(1)
petemantx
10/12/2018 12:27:38 PM
49846
It is amazing reading how varied are the pathways
(2)
petemantx
10/12/2018 12:23:29 PM
49845
Innovation Pharmaceuticals Brilacidin as a Novel
(3)
4kids
10/12/2018 12:20:13 PM
49844
Nice. They just keep connecting thise Celgene
Squar
10/12/2018 12:15:49 PM
49843
Innovation Pharmaceuticals Brilacidin as a Novel
(1)
BooDog
10/12/2018 12:15:12 PM
49842
IPIX News PDE4
(4)
smokenhot
10/12/2018 12:06:58 PM
49840
Well, with all the IPIX wealth we will soon have
Squar
10/12/2018 11:51:21 AM
49839
Ugh. Opdivo doesn't work for lung cancer.
Drano
10/12/2018 11:37:58 AM
49838
Absolutely. Just get ahold of a federal combined
(2)
BooDog
10/12/2018 10:06:59 AM
49837
"It's called distort and it has worked great
(4)
Kelt
10/12/2018 9:56:49 AM
49836
It's clear that people can't do their own
(5)
bejamin
10/12/2018 9:52:03 AM
49835
" All the recent volume is selling pressure.."
(5)
Kelt
10/12/2018 9:49:50 AM
49833
Many of the large non-profits like the cancer
(5)
Drano
10/12/2018 9:45:30 AM
49832
Every stock carries with it a RISK/REWARD factor.
(1)
NotRichYet2
10/12/2018 9:42:42 AM
49831
You attack the moderators and the bullish
(5)
Drano
10/12/2018 9:39:46 AM
49830
Yes, everyone that has been long this stock and
(1)
Jimmyboy
10/12/2018 9:24:41 AM
49829
I thought it was set up to be able to discuss
(5)
bejamin
10/12/2018 9:19:07 AM
49828
Let's see the partnership or BTD news in the next
BooDog
10/12/2018 9:17:56 AM
49827
JUST FOR THE RECORD --- DRANO is "NOT" the only
(2)
NotRichYet2
10/12/2018 9:17:12 AM
49826
That's what the ignore feature is for. Or at
(2)
BooDog
10/12/2018 9:05:29 AM
49825
This board was set up, I thought, to counter IHUB
(11)
petemantx
10/12/2018 9:02:37 AM
49824
Mo: Thanks for making it clear for all who own
(4)
AlanC
10/12/2018 8:59:03 AM
49823
I have a major beef with the Cancer Society but
(4)
petemantx
10/12/2018 8:57:33 AM
49822
Yes not following blindly and creating discussion
(4)
bejamin
10/12/2018 8:57:18 AM
49821
AGREE generally to all that is in your post. That
(4)
NotRichYet2
10/12/2018 8:33:57 AM
49820
A very reasonable analysis Mo. I think if we had
(2)
Squar
10/12/2018 7:40:56 AM
49819
I have reread the Preferred Stock and Warrant
(14)
Mo
10/12/2018 12:19:51 AM
49818
It's because he's been busy here and forgot to go
Drano
10/11/2018 11:28:51 PM
49817
Handy, all you have to do is look in the mirror
Drano
10/11/2018 11:28:04 PM
49816
Haha. Scotty is asleep on the job it
Squar
10/11/2018 10:27:35 PM
Newer
Older
Recent Articles
Former CIA Officer Discusses AI Project Impact on America
Elliott Investment Management's Support for Workday's Future
The Journey of a $1000 Microsoft Investment Over 20 Years
Clorox Company Announces New Quarterly Dividend of $1.24
Savara Inc. Investors Get Opportunity for Class Action Suit
Investors Take Action in Lockheed Martin Securities Case
Investigation Launch by Rosen Law for Encompass Health Investors
Elliott Investment Management's Progressive Outlook on Workday
Landmark Study Highlights NobleStitch™ PFO Closure Benefits
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status
Investors Stand United in LifeMD Securities Fraud Case
Exciting Developments in StubHub's Initial Public Offering
Brookfield Global Infrastructure Fund Declares Quarterly Dividend
Fly-E Group Faces Important Class Action Deadline for Investors
The Growth Journey of Dell Technologies Stock Over Five Years
Veteran Author Fosters Community Connections Through Book Event
Brookfield Announces Quarterly Distribution for Investors
Launched Investigation into Lesaka Technologies for Shareholders
Legal Guidance for CTO Realty Growth Investors Ahead of Deadline
A Remarkable Journey: The Growth of Starbucks Over 20 Years
Investors Have a Chance to Lead the Snap Inc. Lawsuit
Innovative Hair Care Solutions from Magic Sleek for All Types
Navigating Retirement: Rediscovering Purpose Beyond Work
How a $1000 Investment in OSI Systems Could Flourish
How $1000 in Cencora Became Over $6000 in Just 10 Years
Onyx Gold Secures $15 Million in Strategic Financing Deal
Investors Alert: Unicoin, Inc. Class Action Investigation
Honoring Ryan Silver: A Leader in College Basketball Impact
Leadership Changes at NanoXplore: A New Chapter Begins
SelectQuote's Legal Challenges: What Investors Should Know
G-P Recognized as a Pioneering Leader in EOR Solutions
KinderCare Faces Legal Challenges Amid Child Safety Allegations
Court's Ruling Protects Ontario's Water Supply from IEUA Deal
Celebrating Leadership Excellence: David M. Sullivan II's Impact
Celebrating Dr. Erica S. Becker: A Leading Oral Surgeon
How Supplier Onboarding Shapes Long-Term Business Relationships
Rosen Law Firm Urges Snap Inc. Investors to Take Action
aTyr Pharma's Share Turmoil: Investigating the Miscommunication
Turning Small Investments into Substantial Returns: F5's Journey
Exploring BlackRock's Transition of Mutual Funds to ETFs
How $100 in Lam Research Became a Remarkable Investment
LifeMD Faces Class Action Lawsuit Over Misleading Claims